Futura Medical PLC Remuneration of Non-Executive Directors and TVR (7603A)
03 January 2018 - 2:50AM
UK Regulatory
TIDMFUM
RNS Number : 7603A
Futura Medical PLC
02 January 2018
For immediate release 2 January 2018
Futura Medical plc
("Futura" or "the Company")
Remuneration of Non-Executive Directors and Total Voting
Rights
Futura Medical plc (AIM: FUM), the innovative healthcare company
focused on advanced transdermal technology, announces the issue of
37,320 new ordinary shares of 0.2 pence each in respect of the 2017
remuneration of its Non-Executive Directors.
In accordance with the terms of their service agreements,
Non-Executive Directors receive approximately 30 per cent of their
remuneration in the Company's ordinary shares. For 2017 these were
issued at 57.50 pence per share, being the average closing
mid-price of the last 10 trading days of 2016 (as announced via RNS
on 10 January 2017).
The 37,320 new ordinary shares shall rank pari passu with the
existing issued ordinary shares of the Company and have been issued
as follows:
Director Number of ordinary shares Total number of ordinary Percentage of the
issued for 2017 shares held Company's issued share
remuneration capital
John Clarke 26,290 198,976 0.16%
Jonathan Freeman 11,030 63,565 0.05%
Application has been made to the London Stock Exchange and it is
anticipated that trading of the new ordinary shares will commence
on AIM at 8:00am on Monday 8 January, 2018.
Immediately following the above issue, the Company will have
120,696,002 ordinary shares in issue. Since the Company currently
holds no shares in treasury, the total number of voting rights in
the Company is therefore 120,696,002 and this figure may be used by
Shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change in their interest in, the share capital of the Company
under the FCA's Disclosure Guidance and Transparency Rules.
The shares element of the Non-Executive Directors' remuneration
for 2018 will be awarded at 25.10 pence per ordinary share, being
the average closing mid-price of the last 10 trading days of 2017.
The Non-Executive Directors will receive these shares at the end of
the 2018 financial year.
Further details are contained within the notifications below,
made in accordance with Article 19 of the EU Market Abuse
Regulation 596/2014. Full details of Non-Executive Directors'
remuneration will be included in the Company's Annual Report &
Accounts.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
+ 44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Liz Yong / Jens Ehrenburg
+44 (0) 20 7496 3000
For media enquiries please contact:
Buchanan
Mark Court / Sophie Wills / Stephanie Watson
+ 44 (0) 20 7466 5000
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops
innovative products for consumer healthcare. The Company is
developing a portfolio of products and its strategy is to license
their manufacture and distribution to major pharmaceutical and
healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
------- ------------------------------------------------------------------------
a) Name John Clarke
------- ------------------------------ ----------------------------------------
2 Reason for the notification
------- ------------------------------------------------------------------------
a) Position/status Director/ PDMR
------- ------------------------------ ----------------------------------------
b) Initial notification Initial notification
/Amendment
------- ------------------------------ ----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------- ------------------------------------------------------------------------
a) Name Futura Medical plc
------- ------------------------------ ----------------------------------------
b) LEI 21380053QLT46UNV2303
------- ------------------------------ ----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------- ------------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------- ------------------------------ ----------------------------------------
b) Nature of the transaction Issue of shares
------- ------------------------------ ----------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------- --------------
57.50 pence 26,290
----------------- --------------
------- ------------------------------ ----------------------------------------
d) Aggregated information
- Aggregated volume Not applicable
- Price
------- ------------------------------ ----------------------------------------
e) Date of the transaction 2 January 2018
------- ------------------------------ ----------------------------------------
f) Place of the transaction Outside of trading venue
------- ------------------------------ ----------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
------- ------------------------------------------------------------------------
a) Name Jonathan Freeman
------- ------------------------------ ----------------------------------------
2 Reason for the notification
------- ------------------------------------------------------------------------
a) Position/status Director/ PDMR
------- ------------------------------ ----------------------------------------
b) Initial notification Initial notification
/Amendment
------- ------------------------------ ----------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------- ------------------------------------------------------------------------
a) Name Futura Medical plc
------- ------------------------------ ----------------------------------------
b) LEI 21380053QLT46UNV2303
------- ------------------------------ ----------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------- ------------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------- ------------------------------ ----------------------------------------
b) Nature of the transaction Issue of shares
------- ------------------------------ ----------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------- --------------
57.50 pence 11,030
----------------- --------------
------- ------------------------------ ----------------------------------------
d) Aggregated information
- Aggregated volume Not applicable
- Price
------- ------------------------------ ----------------------------------------
e) Date of the transaction 2 January 2018
------- ------------------------------ ----------------------------------------
f) Place of the transaction Outside of trading venue
------- ------------------------------ ----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCELLFBVFFEBBB
(END) Dow Jones Newswires
January 02, 2018 10:50 ET (15:50 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024